mbg-logo-500px

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs. 

mbg-portfolio-sidebar-hepaterambg-portfolio-sidebar-neuromaxmbg-portfolio-sidebar-infectexmbg-portfolio-sidebar-eleventambg-portfolio-sidebar-osterosmbg-portfolio-sidebar-photonicsmbg-portfolio-sidebar-oncomaxmbg-portfolio-sidebar-metamaxmbg-portfolio-sidebar-cardionova

Biotechnology company
Home > Team

Julia S. Moskot

Julia S. Moskot

Graduated from Chelyabinsk State Medical Academy, was engaged in research activities.

Since 2008 engaged in conducting clinical trials in companies such as GlaxoSmithKline and Celgene International. Since 2012, as part of Maxwell Biotech Group participates in the planning and organization of clinical studies as well as their regulatory support.

Daria Tolyneva

Clinical Operations Manager

Graduated from Lomonosov Moscow State University, was engaged in research activities in Institute of Carcinogenesis and Institute of Gene Biology.

Since 2013 was working in Telomerase Activation Sciences as a key account manager. Since 2014 engaged in organizing and conducting clinical trials in Maxwell Biotech Group. Responsible for cooperation with CRO and clinical sites. Involved in monitoring quality of work performed by Russian and foreign vendors and in verifying data provided by central laboratories. Experienced in scientific biomedical literature analysis, preparing documents for preclinical and clinical trials, for registration dossier and submission to the regulatory authorities.

 

© Eleventa, 2012—2020